Register today for the lowest rate of the year

MjBiz Daily’s European Cannabis Symposium is postponed

MJBizDaily’s European Cannabis Symposium is postponed Updated March 18, 2020   In recognition of the current state of emergency created by the COVID-19 pandemic and after considering the emergency response from various governments, the World Health Organization and our host country Denmark, we are postponing MJBizDaily’s European Cannabis Symposium. While serving our customers and building the […]

Read More…

David Henn

David is the founder and CEO of Cannamedical. He is a key driver of the Company’s growth, on-going vision and structuring. David’s primary focus has been to generate strategic partnerships around the globe, executing growth opportunities and fund raising. He is responsible for overseeing all general management for the organization, advancing corporate market strategy, regulatory […]

Read More…

Robert Cookson

Robert Cookson is a London-based Senior consultant in the legal cannabis industry at Hanway Associates. He advises companies on how to enter and build their businesses in the nascent but rapidly-growing European market. His work includes regulatory forecasting, competitive analysis and market sizing. Previously, worked as a journalist at the Financial Times in London and […]

Read More…

Antonio Costanzo

Antonio Costanzo is an experienced senior executive with a successful track record in public and private companies and in innovative, complex and highly regulated industries. He is the co-founder and CEO of EMMAC, a company that brings together scientific research with innovations in medical cannabis cultivation, extraction, and production. Before co-founding EMMAC, he was instrumental […]

Read More…

Christian Carlsen

Christian is the creator and leader of a cannabis business division at NNE (Novo Nordisk Engineering) A/S who help medical cannabis investors and operators across the world from investment to fully operational and GMP certified operation. Christian has previously been working for a broad range of global pharma companies and has a long track record of […]

Read More…

Brian Mertz

Brian is an experienced investor and entrepreneur with extensive C-Suite level experience. He has been involved in the cannabis space since 2015 and founded Medican A/S in 2017. Medican is a licensed pharmaceutical cannabis company based in Denmark with the goal of providing patients throughout the world with medical grade cannabis. Prior to this, Brian […]

Read More…

Andrew De Roy

With over ten years of experience in the commercial intelligence and investigations field, Andrew de Roy is regarded as one of the foremost specialists in the CEE region. Prior to founding Bearstone, Andrew was employed by the Financial Times Group, as the Mergermarket bureau chief in Poland. A leading provider of M&A intelligence and market […]

Read More…

Benedikt Sons

Benedikt is CEO and co-founder of Cansativa, a GMP- and GDP-certified pharmaceutical and medical cannabis import and distribution company. Prior to co-founding Cansativa, Benedikt worked in the field of strategy consulting within pharma and automotive industry. He led several teams in the fields of sourcing and procurement strategy, value engineering, supply chain optimization and cost-down […]

Read More…

Linus Maximilian Weber

Linus Maximilian Weber is an experienced Business Consultant, Founder and CEO in the health care industry at Nimbus Health. He is a certified Project Management Consultant and GDP Responsible for the pharmaceutical distribution business.  The focus of Nimbus Health is to improve the well being of patients by giving consistent and standardized access to alternative […]

Read More…

Narbe Alexandrian

Narbé Alexandrian is the President and Chief Executive Officer of Canopy Rivers Inc., a venture capital firm specializing in cannabis. He also currently serves as a board member for the National Cannabis Industry Association. Prior to joining Canopy Rivers, Narbé was a Senior Associate at OMERS Ventures, a technology venture capital funds in Canada. Prior […]

Read More…

What is the European Cannabis Symposium?

MJBizDaily’s European Cannabis Symposium is the conference that delivers the most objective, unbiased view of the opportunities, challenges and nuances of doing business in the complex European cannabis industry. Cannabis business executives, entrepreneurs and investors seeking increased brand exposure and profitability in the European cannabis marketplace will benefit from this two-day event with actionable intelligence […]

Read More…

Learning from the Tech Boom

In this session, the audience will hear from a successful entrepreneur from a mainstream industry that understands the ebbs and flows of a new field and how to adjust accordingly.  In this session, you will gain insights on:  How to create a flexible business that can adapt to abrupt market changes  What to do when capital dries up and prepare for the inevitable  […]

Read More…

Beyond CBD: Opportunities in Industrial Hemp

As the Novel Foods Directive adds a layer of complexity to the CBD and hemp-derived foods market, it lays open the opportunities available for industrial hemp products including fibers, bioplastics, biofuel, and more. In this session, you will gain insights on: –       Market potential for industrial hemp products –       Regulations to contend with when producing hemp –       Practical […]

Read More…

Action Items: Writing Your Novel Food Designation Application

In November of 2019, German authorities ruled that CBD cannot be marketed or sold without additional research in EU countries. Though arguments could be made about whether hemp should be considered a novel food, this session will examine the steps toward gaining the Novel Foods Designation.  In this session, you will gain insights on:  What you need to prepare for your Novel Foods Designation application  […]

Read More…